Where does Novo Nordisk A/S rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novo Nordisk A/S ranks #893 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novo Nordisk A/S hold?

Novo Nordisk A/S holds 503 US utility patents granted between 2015 and 2025, spanning 63 technology areas.

What is Novo Nordisk A/S's Innovation Score?

Novo Nordisk A/S has an Innovation Score of 61.4 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Novo Nordisk A/S's patent grant rate increasing or decreasing?

Novo Nordisk A/S's recent grant velocity is -28% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Novo Nordisk A/S's patents?

Novo Nordisk A/S's patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novo Nordisk A/S patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novo Nordisk A/S

Q: What technology areas does Novo Nordisk A/S focus on?

Novo Nordisk A/S's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 228 patents, ranking #30 of 3,490 assignees active in that subclass. Grants appear in 63 CPC subclasses total.

USPTO PatentsView assignee record - 503 granted patents across 63 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novo ranks #893 of 49,997 tracked US assignees by granted-patent volume, with 503 patents across 63 technology areas.

#893
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.4/100): 14.3
avg claims per patent: -28%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R893 · Foreign Corporation #893 · 503 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 503 grants
TOP-DECILE #893/49,997
PHOTO-FINISH KLA
CPC-WIDE A61M · 63 areas
INNOV-STRONG 61.4/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -28% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: KLA Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novo’s 61.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 21.5 pts (35%) Velocity 6.3 pts (10%) Breadth 25.0 pts (41%) Claim depth 8.6 pts (14%)

Qualcomm Incorporated · highest

85
Husqvarna AB · near

61
Sleep Number · near

61
Acucela · near

61
Ethicon · near

61
Novo Nordisk A/S · this assignee

61
3D Lighting… · lowest

7

What this shows Novo's Innovation Score is 61.4/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novo?

Each dot is one of Novo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novo’s own 14.3 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Novo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Novo's grant cadence moved

Between 2020–2024, Novo Nordisk A/S received 201 grants versus 278 in 2015–2019 (-28% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 66 grants and bottomed in 2024 at 32. Lead class A61M accounts for 45.3% of the portfolio across 63 subclasses. Volume neighbours: Sumitomo Metal Mining Co., Ltd. (#889) and Atlassian PTY Ltd. (#897).

Novo's three-year grant acceleration

From 2019–2021 to 2022–2024, Novo Nordisk A/S moved from 132 to 125 grants (0.95x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,329. See the growth leaderboard.

Sumitomo Metal Mi…

511
Entegris

509
Nuvasive

504
KLA

503
Novo Nordisk A/S ◀

503
FEI

502
Nidec Sankyo

502
Airbus Helicopters

501
Atlassian PTY

500

What this shows Novo holds 503 patents at rank #893, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novo

By rank, the assignees closest to #893 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Novo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Novo ranks #30 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Ethicon, Inc. 61 Acucela Inc. 61 Husqvarna AB 61 Sleep Number Corporation 61

Similar claim depth

Nearest assignees by average claims per patent (14.3 here).

JSR Corporation 14.3 avg Sidel Participations S.A.S 14.3 avg Singapore Health Services PTE. Ltd. 14.3 avg Saint Louis University 14.3 avg

Novo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novo Nordisk A/S patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	66	13.1%
2016	53	10.5%
2017	53	10.5%
2018	50	9.9%
2019	56	11.1%
2020	34	6.8%
2021	42	8.3%
2022	57	11.3%
2023	36	7.2%
2024	32	6.4%
2025partial year	24	4.8%

Which technologies does Novo Nordisk A/S patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 228

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 206

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 199

C07K - Peptides 189

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 46

A61B - DIAGNOSIS; SURGERY; Identification 27

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 21

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 10

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 8

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 7

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 6

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 6

C12Y - Enzymes 5

Y10T - Technical Subjects Covered BY Former US Classification 5

Top 15 of 63 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novo Nordisk A/S's patent record in context - here's where to go next.

Novo Nordisk A/S's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 45.3% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #893 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novo Nordisk A/S against Sumitomo Metal Mining Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.